Status:
ENROLLING_BY_INVITATION
Exparel Injection Effect on Postoperative Opioid Usage
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Thyroid
Parathyroid Adenoma
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The question proposed by this study, is one of patient outcomes. Does intraoperative injection of Exparel decrease postoperative use of opioid pain medications in patients undergoing thyroid and parat...
Detailed Description
Patients will be identified in clinic as good candidates for surgical intervention based on current standard of care. Once participants are consented, they will be randomly placed into one of three ca...
Eligibility Criteria
Inclusion
- Patients over the age of 18 years Patients requiring parathyroid/thyroid surgery based on the standard of care English as primary language
Exclusion
- Patients under the age of 18 years Patients with previous history of opioid abuse Patients with a true allergy to any local anesthetic Patients with a true allergy to any opioid
Key Trial Info
Start Date :
September 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04085913
Start Date
September 30 2019
End Date
July 1 2025
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri
Columbia, Missouri, United States, 65212